Cytokine Profile and Immunomodulation in Asymptomatic Human T‐Lymphotropic Virus Type 1‐Infected Blood Donors
暂无分享,去创建一个
E. Carvalho | F. Neva | Edgar M. Carvalho | Olívia Bacellar | Aurélia F. Porto | Silvane Braga | Bernardo Galvão‐Castro | Franklin Neva | O. Bacellar | B. Galvão-Castro | A. Porto | S. Braga
[1] W. Blattner,et al. SPONTANEOUS LYMPHOCYTE PROLIFERATION IN SYMPTOM-FREE HTLV-I POSITIVE JAMAICANS , 1989, The Lancet.
[2] K. Eguchi,et al. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy. , 1999, Internal medicine.
[3] J. Banchereau,et al. Interferon gamma inhibits interleukin 10 production by monocytes , 1993, The Journal of experimental medicine.
[4] T. Mosmann,et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.
[5] H. Tsuda,et al. Interleukin‐2 Prevents Programmed Cell Death in Adult T‐Cell Leukemia Cells , 1993, Japanese journal of cancer research : Gann.
[6] M. Kaplan. Human retroviruses and neoplastic disease. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] C. Brodskyn,et al. Cytotoxicity in patients with different clinical forms of Chagas' disease , 1996, Clinical and experimental immunology.
[8] W. Blattner,et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. de Carli,et al. Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I. , 1998, The Journal of general virology.
[10] F. Proietti,et al. Distribution of human T‐lymphotropic virus type I among blood donors: a nationwide Brazilian study , 1997, Transfusion.
[11] S. Jacobson,et al. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. , 1998, Journal of immunology.
[12] A. Allison,et al. Identification of human mononuclear leucocyte populations by esterase staining. , 1977, Clinical and experimental immunology.
[13] D. Hafler,et al. Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. , 1997, Blood.
[14] D. Mattson,et al. Immunological studies in tropical spastic paraparesis , 1990, Annals of neurology.
[15] R. Badaró,et al. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. , 1989, The Journal of clinical investigation.
[16] E. Carvalho,et al. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. , 1998, The Journal of infectious diseases.
[17] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[18] D. Taub,et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. , 1997, Journal of immunology.
[19] A. Fauci,et al. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. , 1984, Science.